Zelira Therapeutics Limited Promotes Greg Blake from VP - Global Head of Commercial and Partnering to Executive Director
Greg has held leadership roles at large multinationals (J&J and CSL) and publicly-listed biotech start-ups.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.67 AUD | -3.60% | -1.47% | -25.56% |
1st Jan change | Capi. | |
---|---|---|
-25.56% | 5.21M | |
+2.97% | 108B | |
+10.21% | 104B | |
+1.57% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |